OpenAlex
PricingAboutJobs
Log inGet started
Work

Development of Ipilimumab: Contribution to a New Paradigm for Cancer Immunotherapy

HTML

Year: 2010
Type: review
Source: Seminars in Oncology
DOI: 10.1053/j.seminoncol.2010.09.015
Authors: Axel Hoos, Ramy Ibrahim, Alan Korman, Kald Abdallah, David Berman, Vafa Shahabi, Kevin Chin, Renzo Canetta, Rachel Humphrey
Institution: Bristol-Myers Squibb (United States)
Language: English

Topic: Cancer Immunotherapy and Biomarkers
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Keywords: ipilimumab, CTLA-4, cancer immunotherapy, advanced melanoma, immune-related adverse events, immune checkpoint blockade, antitumor T-cell responses, overall survival, pharmacokinetics, combination therapy
SDG: Good health and well-being

Open Access status: closed

Funder: Bristol-Myers Squibb
OpenAlex ID: W2055175265
FWCI: 2.662
Cites: 85
Cited by: 252
Related to: 9
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Supporters
Legal
Privacy
Accessibility
Terms